R R Maag AG博士发现了一系列新型的7-(4,6-二甲氧基嘧啶-2-基)氧基-和-硫代-3-甲基-1(3H)-异苯并呋喃酮。从硫代-异苯并呋喃基系列中,选择CGA 279 233(BSI提出的通用名称pyrpidalid)作为水稻中的除草剂进行进一步开发。给出了这些新的邻苯二甲酸衍生化合物的一般合成方法,重点是吡苯哌啶的合成及其理化行为。
Concise Process for Pyriftalid Synthesis by Introducing the Mercapto Group Directly from a Nitro Group
作者:Zhong Li、Yong-Jian Chi、Yi-Wen Huang
DOI:10.1021/acs.oprd.1c00384
日期:2022.2.18
A concise and efficient process for the synthesis of pyriftalid is described herein. The improved process features the direct introduction of the mercapto group by one-step substitution of a nitro group using sodium sulfide and elemental sulfur. A systematic study of the key step is also carried out in this article. Compared with previous routes, the optimized route is shorter and avoids a hazardous
Quinoline-3-carboxamide compounds and their use in diagnosis
申请人:Westfaelische Wihelms-Universitaet Muenster
公开号:US10350315B2
公开(公告)日:2019-07-16
The present application provides quinoline-3-carboxamide compounds covalently linked to a label for use in the diagnosis of an inflammatory disease at local site. The above mentioned compounds can be used to detect or image accumulation of S100A9 in the body of a subject at sites of inflammation, using in vivo non-invasive molecular imaging techniques for the detection of said compounds. Accordingly, labeled quinoline-3-carboxamide compounds can be applied to evaluate the risk of a subject of developing an inflammatory disease and to follow the progress of the disease.
QUINOLINE-3-CARBOXAMIDE COMPOUNDS AND THEIR USE IN DIAGNOSIS
申请人:Westfälische Wilhelms-Universität Münster
公开号:EP3212239A1
公开(公告)日:2017-09-06
[EN] QUINOLINE-3-CARBOXAMIDE COMPOUNDS AND THEIR USE IN DIAGNOSIS<br/>[FR] COMPOSÉS DE QUINOLINE-3-CARBOXAMIDE ET LEUR UTILISATION EN DIAGNOSTIC
申请人:UNIV MUENSTER WILHELMS
公开号:WO2016067238A1
公开(公告)日:2016-05-06
The present application provides quinoline-3-carboxamide compounds covalently linked to a label for use in the diagnosis of an inflammatory disease at local site. The above mentioned compounds can be used to detect or image accumulation of S100A9 in the body of a subject at sites of inflammation, using in vivo non-invasive molecular imaging techniques for the detection of said compounds. Accordingly, labeled quinoline-3-carboxamide compounds can be applied to evaluate the risk of a subject of developing an inflammatory disease and to follow the progress of the disease.